Even as researchers seek out biomarkers to predict ketamine reaction, clinicians uncover them selves with a conundrum: Which patients really should start with IV ketamine, and which with Spravato? And the way do the two compare head to head in precise response to treatment? In addition to the chronic treatment https://ericj555cqf2.is-blog.com/profile